"The new factory...is a joint venture between QCI and the Indian pharmaceutical Cipla. It will produce Triomune, a combination that contains lamavudine, stavudine and nevirapine. Out of 80,000 people on ARVs in Uganda, three-quarters are taking Triomune."
Saturday, October 06, 2007
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment